| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
MBD3 (Methyl-CpG-binding domain protein 3) serves as a critical component of the NuRD (nucleosome remodeling and deacetylase) complex, playing essential roles in transcriptional regulation and chromatin remodeling. As a methyl-CpG-binding protein, MBD3 participates in epigenetic mechanisms that control gene expression patterns, making it a valuable target for researchers investigating chromatin dynamics, developmental biology, and disease-associated epigenetic alterations.
This recombinant rabbit monoclonal antibody (clone 11A5) offers the reproducibility and consistency that demanding epigenetics research requires. Generated against a synthetic peptide derived from human MBD3, the recombinant format ensures sequence-defined specificity and eliminates the lot-to-lot variability that can compromise longitudinal studies or multi-site collaborations.
Validation across multiple platforms demonstrates this antibody's versatility in your experimental workflows. Western blot analysis confirms reliable detection in COLO205 human colorectal carcinoma cells as well as mouse and rat brain tissue lysates, with observed bands at 33 and 35 kDa. The appearance of a secondary band slightly above the predicted 33 kDa molecular weight likely reflects post-translational modifications such as glycosylation or phosphorylation, which are common for chromatin-associated proteins. Immunohistochemistry validation in human placenta tissue sections shows clear nuclear staining patterns consistent with MBD3's chromatin-associated function, while flow cytometry analysis in HeLa cells demonstrates suitability for single-cell quantification approaches.
With confirmed cross-species reactivity spanning human, mouse, and rat samples, this antibody supports comparative studies across model systems commonly used in epigenetic research. Whether investigating NuRD complex function, chromatin remodeling mechanisms, or epigenetic contributions to disease states, this MBD3 antibody provides a dependable tool for your nuclear signaling investigations.
Email: support@cusabio.com
Distributors Worldwide